The authors demonstrated that the ischemia-induced upregulation of NF-κB and MMP9 were reduced following NOB injection, suggesting that NOB’s therapeutic impact in ischemic stroke may be linked to a lower expression of MMP9 and NF-κB genes [24]. The gene discussed is MMP9; the disease is ischemic stroke.